Tyra Biosciences
TYRA
TYRA
113 hedge funds and large institutions have $676M invested in Tyra Biosciences in 2024 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 34 increasing their positions, 25 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
36% less call options, than puts
Call options by funds: $53K | Put options by funds: $83K
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
39% less capital invested
Capital invested by funds: $1.11B → $676M (-$430M)
Holders
113
Holding in Top 10
5
Calls
$53K
Puts
$83K
Top Buyers
| 1 | +$13.9M | |
| 2 | +$13.8M | |
| 3 | +$9.75M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$9.45M |
| 5 |
Pictet Asset Management
Carouge,
Switzerland
|
+$4.92M |
Top Sellers
| 1 | -$17.2M | |
| 2 | -$12M | |
| 3 | -$9.97M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$3.86M |
| 5 |
Jennison Associates
New York
|
-$3.72M |